Adult Diffuse Astrocytoma

Search with Google Search with Bing
Information
Disease name
Adult Diffuse Astrocytoma
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT01165632 Active, not recruiting Early Phase 1 Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma July 26, 2010 December 30, 2024
NCT01417507 Completed Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery October 2011 December 2014
NCT01635283 Completed Phase 2 Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma January 10, 2012 May 13, 2016
NCT00499473 Completed Phase 2 Sunitinib in Treating Patients With Recurrent Malignant Gliomas June 2007 October 2014
NCT02186509 Completed Phase 1 Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas January 30, 2015 December 31, 2018
NCT00030498 Completed Phase 1 Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction December 2001
NCT00492089 Completed Phase 2 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer June 2007 August 2010
NCT01024907 Completed Phase 1/Phase 2 Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas December 17, 2009 February 2014
NCT01051557 Completed Phase 1/Phase 2 Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma January 27, 2010 September 30, 2020
NCT00112736 Completed Phase 1/Phase 2 Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma April 2005 April 2014
NCT01119599 Completed Phase 1 RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma May 2010
NCT00823459 Completed Phase 2 Everolimus in Treating Patients With Recurrent Low-Grade Glioma January 23, 2009 November 13, 2017
NCT02967380 Terminated N/A Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases December 14, 2011 October 14, 2015
NCT00110032 Terminated Phase 1 Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors June 2005
NCT00430079 Terminated N/A Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma July 2001
NCT01103375 Terminated Phase 1 Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma May 2010 March 2013
NCT01234805 Terminated N/A Yoga Therapy in Treating Patients With Malignant Brain Tumors December 2010 September 2012
NCT02175745 Terminated N/A 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas December 2014 December 2015
NCT02194452 Withdrawn N/A Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors September 2013 March 2017